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Abstract
Background: A prolonged operative time is associated with adverse post-operative outcomes in laparo-
scopic surgery. Although a single-incision laparoscopic cholecystectomy (SILC) requires a longer opera-
tive time as compared with a conventional laparoscopic cholecystectomy, risk factors for a prolonged
operative time in SILC remain unknown.
Methods: A total of 20 clinical variables were retrospectively reviewed to identify factors for a prolonged
operative time (longer than 3 h) in a total of 220 consecutive patients undergoing SILC.
Results: The median operative time was 145 min (range, 55–435) and a prolonged operative time was
required in 62 patients (28%). Independent factors that predict a prolonged operative time as identified
through multivariate analysis were body mass index (BMI) (P = 0.009), acute cholecystitis (P < 0.001) and
operator (resident or staff surgeon) (P < 0.001). Furthermore, a prolonged operative time was significantly
associated with an increased amount of intra-operative blood loss (P < 0.001) and a prolonged stay after
surgery (P < 0.001).
Conclusions: These findings suggest that a higher BMI, acute cholecystitis and a resident as an
operator significantly increase the duration of SILC procedures.
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Introduction
A laparoscopic cholecystectomy (LC) has long been recognized as
the gold standard procedure for removal of the gallbladder.
Recently, a single-incision laparoscopic cholecystectomy (SILC),
also called as transumbilical LC or laparoendoscopic single site
(LESS) cholecystectomy, has been developed to further minimize
the invasiveness of LC by reducing the number of incisions.1–3
Although questions still remain as to the safety, absolute benefits
and long-term outcomes of the procedure, recent randomized
controlled trials have shown that SILC can provide, at least in part,
better cosmetic results as compared with conventional LC.4–10 On
the other hand, SILC requires a longer operative time as compared
with conventional LC.7,10–12
It has been recently shown that an increased operative time is
associated with increased complication rates in various laparo-
scopic surgeries.13 In conventional LC, a prolonged operative time
has been reported to result in increased rates of post-operative
complications (such as bile duct injury and bleeding) and a pro-
longed hospital stay.14 In a retrospective analysis including a total
of 601 patients undergoing conventional LC, a significantly higher
post-operative morbidity rate was noted in patients who had a
procedure longer than 2 h than in patients whose surgery required
less than 2 h (13.6% versus 3.6%, P < 0.001).15 Previous studies
have identified male gender, obesity, previous upper abdominal
surgery, acute cholecystitis, intra-abdominal adhesions and a low
degree of surgical expertise as risk factors predicting a prolonged
operative time in conventional LC.14,16
Considering that the main benefit of SILC appears to be
improved cosmesis, an increased risk of post-operative complica-
tions and a prolonged hospital stay as a result of a prolonged
operative time may not be justified. It is, therefore, important to
understand the factors responsible for an increased operative time
in SILC. In the present study, clinical variables were retrospectively
reviewed to identify factors for a prolonged operative time in a
total of 220 consecutive patients undergoing SILC.
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Patients and methods
Patients
All patients who had attempted SILC from September 2009 to July
2012, at the Department of Surgery, University of Occupational
and Environmental Health (Kitakyushu, Japan) were identified
through a search of clinical database and hospital records. Patients
were excluded if they had an additional procedure (e.g. common
bile duct exploration) at the time of cholecystectomy. This series is
the institution’s initial experience with SILC and there were no
exclusion criteria for performing SILC during the study period.
The diagnosis of acute cholecystitis was made pre-operatively
according to the Tokyo guidelines.17 Briefly, patients exhibiting
one of the local signs of inflammation (such as Murphy’s sign, or
a mass, pain or tenderness in the right upper quadrant), as well as
one of the systemic signs of inflammation (such as a fever, elevated
white blood cell count and elevated C-reactive protein level) were
diagnosed as having acute cholecystitis.
Operative procedure
The technique for SILC used was a three-trocar approach through
a single umbilical incision. Under general anaesthesia, patients
were placed in the supine position with their legs apart. A 2.5-cm
vertical incision was made on the umbilicus, through which a
5-mm trocar (Endopath Xcel; Ethicon Endo-Surgery, Cincinnati,
OH, USA) was introduced for pneumoperitoneum and a laparo-
scope (EndoEye camera system; Olympus Medical System, Tokyo,
Japan). After exposing the abdominal fascia under the skin flap of
the umbilical incision, a grasper for gallbladder retraction was
directly inserted without a trocar by making a pinhole on the
fascia with a needle. Then, two 5-mm trocars (Endopath Xcel,
Ethicon Endo-Surgery, or EZ trocar, Hakko Co., Nagano, Japan)
for the operator’s manipulation were inserted into the abdominal
cavity through the single umbilical incision. In some patients, a
small wound retractor (Alexis wound retractor; Applied Medical,
Rancho Santa Margarita, CA, USA) combined with a surgical
glove (glove method) or a small wound protector (Lap-Protector,
Hakko) combined with a silicon rubber cap (EZ Access; Hakko
Co.) were used as a multichannel port.
Dissection of the Calot triangle was performed carefully
according to the critical view of the safety approach.18 After con-
firming that the cystic artery and cystic duct are the only two
tubular structures remaining between the gallbladder and the
hepatoduodenal ligament, an intra-operative cholangiography
was routinely attempted. In most patients, IOC was performed
using the Kumar cholangiography system (Nashville Surgical
Instruments, Nashville, TN, USA).19 After completion of intra-
operative cholangiography, the cystic duct and cystic artery were
doubly clipped with a 5-mm disposable clip applier and then
divided. The gallbladder was then dissected from the liver bed
using hook electrocautery or Harmonic ACE (Johnson &
Johnson, Cincinnati, OH, USA). The gallbladder was then col-
lected in a bag and removed through the umbilical incision,
usually by enlarging the fascial opening as required. The fascial
defect in the umbilicus was closed using an absorbable monofila-
ment suture and the skin was closed subcuticularly with a 4-0
absorbable monofilament suture.
Definition of a prolonged operative time and clinical
variables for comparison
A prolonged operative time was defined as the upper quartile
(longer than 3 h) according to the distribution. Using this defini-
tion, all patients who underwent an attempted SILC were divided
into two groups: a group of patients who had a procedure less than
3 h (no prolonged operative time group) and patients who
required longer than 3 h to complete the procedure (prolonged
operative time group). Clinical variables analysed were age,
gender, body mass index (BMI), American Society of Anesthesi-
ologists (ASA) score ( 3), comorbid diseases, diabetes mellitus,
prior abdominal surgery (all), prior upper abdominal surgery, a
clinical presentation of acute cholecystitis, operator (surgical resi-
dents or senior staffs), and preoperative values of white blood cell
counts (WBC), total bilirubin (T. Bil.), direct bilirubin (D. Bil.),
aspartate aminotransferase (AST), alanine aminotransferase
(ALT), alkaline phosphatase (ALP), gamma-glutamyl transpepti-
dase (g-GTP) and creatinine. Factors associated with a learning
curve (institution’s first 100 patients and the first 10 patients for
each operator) were also included in the analysis. The number of
10 for each operator was defined according to a previous study
reporting a requirement of 8 procedures to achieve a learning
curve plateau with SILC.20
Statistical analysis
All statistical analyses were done using JMP 10 software (SAS
Institute Inc., Cary, NC, USA). Categorical variables were analysed
using Fisher’s exact probability test and continuous variables were
analysed using the Mann–Whitney U-test. Multivariate analysis
was done for all variables with P-values of less than 0.2 using a
logistic regression analysis. A P-value of less than 0.05 was con-
sidered statistically significant.
Results
Patient characteristics of study population and
overall outcomes
In total, 220 patients with gallbladder diseases (including symp-
tomatic cholelithiasis, acute cholecystitis, and gallbladder polyps)
were identified as having an attempted SILC. The patient charac-
teristics and overall outcomes of the study population are shown
in Table 1.
Identification of factors affecting a prolonged
operative time in SILC
A total of 20 clinical variables were compared between the no
prolonged operative time group (n = 158) and prolonged opera-
tive time group (n = 62) (Table 2). Multivariate analysis revealed
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BMI, acute cholecystitis and operator to be independent factors
predicting the prolonged operative time (Table 3).
Correlation between prolonged operative time and
operative/post-operative outcomes
Comparisons of operative time with operative and post-operative
outcomes (including intra-operative blood loss, post-operative
complications and length of post-operative hospital stay) revealed
a significant association with prolonged operative time and
increased intra-operative blood loss and a longer post-operative
hospital stay (Table 4).
Discussion
In an attempt to identify risk factors that predict the prolonged
operative time in SILC, univariate and multivariate analyses were
used to investigate 20 clinical variables in a total of 220 consecu-
tive patients. The major findings of the present study were as
follows: (i) a prolonged operative time (longer than 3 h) was
required in 62 patients (28%); (ii) on multivariate analysis, inde-
pendent factors predicting a prolonged operative time were higher
BMI, acute cholecystitis and operator (resident); and (iii) a pro-
longed operative time was significantly associated with an
increased amount of intra-operative blood loss and a prolonged
stay after surgery. These findings suggest that a prolonged opera-
tive time is associated with adverse clinical outcomes after SILC
and can be predicted by several preoperative and operative factors,
including BMI, acute cholecystitis and operator.
According to a recent meta-analysis of randomized controlled
trials,7 SILC had a significantly favourable cosmetic scoring com-
pared with conventional LC, whereas the operating time was sig-
nificantly longer in SILC. The mean operative time in the present
series (155 min) was longer than the mean operative time of SILC
(80 min; range, 40–186 min) reported in other papers.21 This may
be attributed to different gallbladder pathology (i.e. a relatively
higher proportion of patients with acute cholecystitis), operator
(almost one-fourth of SILC procedures were done by surgical
residents) and a routine intra-operative cholangiography. In addi-
tion, the effect of a learning curve on the operative time was
examined in the present study, because previous studies have sug-
gested a correlation between learning curve and operative time in
SILC.20,22 However, there were no significant effects of learning
curves, as assessed by the institution’s first 100 patients and first 10
patients for each operator, on the operative time.
It has been shown that a prolonged operative time is associated
with an adverse clinical course, i.e. increased complication rates in
various laparoscopic surgery.13 In conventional LC, a prolonged
operative time has been reported to result in increased rates of
post-operative complications (such as bile duct injury and bleed-
ing) and a prolonged hospital stay.14 In a retrospective analysis
including a total of 601 patients undergoing a conventional LC, a
significantly higher post-operative morbidity rate was noted in
patients who had a procedure longer than 2 h than in patients
whose surgery required less than 2 h (13.6% versus 3.6%, P <
0.001).15 In contrast, a study comparing patients whose conven-
tional LC took 3 h or more and those whose operation took less
than 3 h revealed no significant difference in the rate of post-
operative complications.23 In the present study, no significant dif-
ference was observed in the rate of post-operative complications
between the prolonged operative time group (5%) and no pro-
longed operative time group (4%). However, this study has dem-
onstrated that a prolonged operative time was significantly
associated with a longer post-operative stay. One major concern
raised against the present results is a relatively longer overall stay
in patients undergoing SILC. In fact, the mean length of stay in
patients undergoing SILC of less than 3 h was still long (5.4 3.3
days). In general, the length of stay is longer in Japan as compared
with other Western countries, primarily owing to the differences
in the health insurance systems. Because the medical insurance in
Japan covers the complete cost of hospitalization, most patients
tend to stay longer in hospital until they recover completely from
surgery. Various efforts are currently being made to shorten the
length of stay and reduce the cost of medical care, for example, by
introducing clinical pathways.
Previous studies have identified male gender, obesity, previous
upper abdominal surgery, acute cholecystitis, intra-abdominal
adhesions and low degree of surgical expertise as risk factors for
Table 1 Patient characteristics and outcomes of all the study
population
Factor All patients
(n = 220)
Age (years) 62 (16–91)
Gender (M/F) 91/67
BMI (kg/m2) 22.6 (13.8–46.6)
ASA score
1 68 (31%)
2 140 (64%)
3 7 (3%)
Comorbid diseases (yes) 125 (57%)
Diabetes mellitus (yes) 34 (15%)
Prior abdominal surgery (yes) 80 (36%)
Prior upper abdominal surgery (yes) 10 (5%)
Acute cholecystitis (yes) 30 (14%)
Operator (residents/senior staff) 53/167
Operative time (minutes) 145 (55–435)
Intra-operative blood loss (ml) 5 (0–425)
Post-operative complications 9 (3%)
Wound infection 5
Aspiration pneumonia 2
Bile leakage 1
Delayed abdominal abscess 1
Post-operative hospital stay (days) 5 (2–36)
Values shown are median (range).
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predicting a prolonged operative time in conventional LC.14,16 In
the present study, the most significant risk factor for a prolonged
operative time in SILC was acute cholecystitis. In current surgical
practice, the indication of SILC may be limited to optimal cases
without acute inflammation. However, a few previous studies have
described the feasibility of SILC for the treatment of acute chole-
cystitis.24,25 As a teaching hospital, SILC is attempted even in chal-
lenging patients, including those with severe acute cholecystitis. It
is notable, however, that the mean operative time in patients with
acute cholecystitis was 220 min, which was significantly longer
than than in those without acute inflammation (145 min, P <
0.001). These results may reflect, at least in part, greater technical
difficulties of SILC for acute cholecystitis. Although the safety and
benefits of SILC for acute cholecystitis should be evaluated in
future studies, SILC for acute cholecystitis especially for obese
patients may not be acceptable in the current surgical practice.
The present study has several limitations. First, this study is a
retrospective analysis; therefore, the possibility of bias cannot be
Table 2 Univariate analysis for factors predicting a prolonged operative time in a single-incision laparoscopic cholecystectomy (SILC)
between the no prolonged operative time group and the prolonged operative time group
Factor No prolonged operative
time group (n = 158)
Prolonged operative
time group (n = 62)
P-value
Age (years) 62 (16–87) 63 (16–91) 0.5987
Gender (M/F) 91/67 31/31 0.3660
BMI (kg/m2) 22.1 (13.8–38.5) 24.3 (18.9–46.6) 0.0004a
ASA score ( 3) 5 (3%) 2 (3%) 1.0000
Comorbid diseases (yes) 90 (57%) 35 (56%) 1.0000
Diabetes mellitus (yes) 18 (11%) 16 (26%) 0.0121a
Prior abdominal surgery (yes) 62 (39%) 18 (29%) 0.1652
Prior upper abdominal surgery (yes) 7 (4%) 3 (5%) 1.0000
Acute cholecystitis (yes) 12 (8%) 18 (29%) 0.0001a
Operator (residents/senior staff) 31/127 22/40 0.0219a
Institution's first 100 cases 72 (46%) 28 (45%) 1.0000
First 10 cases for each operator 92 (58%) 41 (66%) 0.3579
WBC (/mm3) 5300 (2100–16900) 5600 (3500–11800) 0.0248a
T. Bil. (g/dl) 0.6 (0.2–2.5) 0.6 (0.3–1.5) 0.5344
D. Bil. (g/dl) 0.2 (0.1–1.6) 0.2 (0.1–1.1) 0.3331
AST (IU/l) 23 (12–223) 22 (11–185) 0.2505
ALT (IU/l) 20 (7–362) 20 (6–350) 0.9540
ALP (IU/l) 244 (128–1973) 236 (144–1150) 0.9291
g-GTP (IU/l) 37 (7–536) 36 (13–1078) 0.4054
Creatinine (mg/dl) 0.7 (0.4–7.1) 0.7 (0.2–7.0) 0.5165
Values shown are median (range).
aStatistically significant.
BMI, body mass index; ASA, American Society of Anesthesiologists; WBC, white blood counts; T. Bil., total bilirubin; D. Bil., direct bilirubin: AST,
aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; g-GTP, gamma-glutamyl transpeptidase.
Table 3 Multivariate analysis for factors predicting a prolonged operative time in a single-incision laparoscopic cholecystectomy (SILC)
Factor Category Odds ratio 95% CI P-value
BMI (kg/m2) per 1 Kg/m2 1.1 1.0–1.2 0.0100a
Diabetes mellitus Yes/No 2.4 1.0–5.6 0.0507
Prior abdominal surgery Yes/No 1.9 0.9–4.0 0.0819
Acute cholecystitis Yes/No 6.2 2.5–16.2 <0.0001a
Operator (residents) Yes/No 4.0 1.9–8.6 0.0003a
WBC (/mm3) per 1 /mm3 1.0 1.0–1.0 0.6061
CI, confidential interval.
aStatistically significant.
BMI, body mass index; WBC, white blood counts.
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eliminated. Second, SILC was performed by many surgeons with
different experiences with this procedure in the present analysis.
Although staff surgeons and residents were compared as a factor
for a prolonged operative time, there may be differences in surgi-
cal skills even among staff surgeons. Furthermore, identification
of a resident as a risk factor for a prolonged operative time may be
because of limited experience as the mean patients per resident
were only 5 as compared with 15 for a staff surgeon.
In summary, the results suggest that a higher BMI, acute chole-
cystitis and resident as an operator significantly increase the dura-
tion of the SILC procedure. Assessment of these factors may help
to establish selection criteria for this procedure and facilitate the
decision on the operating schedule as well as appropriate assign-
ment of operator and assistant residents.
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